Literature DB >> 17294152

[Conservative treatment of male stress incontinence].

S Buse1, A Reitz, A Haferkamp, M Hohenfellner.   

Abstract

The majority of male patients affected by stress incontinence developed this disturbance after radical prostatectomy or less frequently after TURP. Urodynamic evaluation shows sphincter insufficiency in more than 90% of the patients. The conservative therapy of postprostatectomy stress incontinence relies on physical methods, namely, pelvic floor muscle training with or without electrical or magnetic stimulation. However, evidence in favor of one or the other approach is limited. Since publication of the positive results with duloxetine in women, interest in medical therapy for men reporting postoperative stress incontinence has increased. Conclusive evidence in favor of duloxetine for prostatectomy-associated incontinence however is still missing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17294152     DOI: 10.1007/s00120-007-1296-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  36 in total

1.  Effect of preoperative biofeedback/pelvic floor training on continence in men undergoing radical prostatectomy.

Authors:  G T Bales; G S Gerber; T X Minor; D A Mhoon; J M McFarland; H L Kim; C B Brendler
Journal:  Urology       Date:  2000-10-01       Impact factor: 2.649

Review 2.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip Van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Urology       Date:  2003-01       Impact factor: 2.649

3.  Preliminary results of the effect of extracorporeal magnetic stimulation on urinary incontinence after radical prostatectomy: a pilot study.

Authors:  Teruhiko Yokoyama; Miyabi Inoue; Osamu Fujita; Kunihiro Nozaki; Hiroyuki Nose; Hiromi Kumon
Journal:  Urol Int       Date:  2005       Impact factor: 2.089

4.  Urinary incontinence after radical prostatectomy: incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up.

Authors:  Emilio Sacco; Tommaso Prayer-Galetti; Francesco Pinto; Simonetta Fracalanza; Giovanni Betto; Francesco Pagano; Walter Artibani
Journal:  BJU Int       Date:  2006-06       Impact factor: 5.588

Review 5.  Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.

Authors:  Paramananthan Mariappan; Ammar Alhasso; Zoe Ballantyne; Adrian Grant; James N'Dow
Journal:  Eur Urol       Date:  2006-09-15       Impact factor: 20.096

6.  Changes of urodynamic findings after radical retropubic prostatectomy.

Authors:  B Kleinhans; E Gerharz; M Melekos; K Weingärtner; T Kälble; H Riedmiller
Journal:  Eur Urol       Date:  1999       Impact factor: 20.096

Review 7.  Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.

Authors:  Wolfgang Jost; Parvaneh Marsalek
Journal:  Clin Auton Res       Date:  2004-08       Impact factor: 4.435

Review 8.  Conservative management for postprostatectomy urinary incontinence.

Authors:  K F Hunter; K N Moore; D J Cody; C M A Glazener
Journal:  Cochrane Database Syst Rev       Date:  2004

9.  Pelvic floor exercises, electrical stimulation and biofeedback after radical prostatectomy: results of a prospective randomized trial.

Authors:  S Wille; A Sobottka; A Heidenreich; R Hofmann
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

10.  Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy.

Authors:  W J Catalona; J W Basler
Journal:  J Urol       Date:  1993-09       Impact factor: 7.450

View more
  1 in total

1.  [Conservative management of postoperative urinary incontinence in men].

Authors:  J N Nyarangi-Dix; D Schultz-Lampel; U Hohenfellner; J Huber; G Hatiboglu; N Djakovic; A Haferkamp; M Hohenfellner
Journal:  Urologe A       Date:  2010-04       Impact factor: 0.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.